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The title compound, C17H12BrN3O2, was unexpectedly isolated during an
attempt to synthesize pyridodiazepinediones and identified as an oxazolo-
naphthyridinone derivative. The almost planar oxazolonaphthyridinone ring
(r.m.s. deviation = 0.016 A˚) makes a dihedral angle of 61.6 (2) with the phenyl
ring. In the crystal, columns of molecules stacked along the a axis are formed by
– interactions between the six-membered rings of the oxazolonaphthyridone
moieties [centroid-to-centroid distances = 3.494 (2)–3.906 (3) A˚], which further
interact through C—H   contacts with the phenyl rings.
1. Chemical context
While benzodiazepine drugs have been amongst the most
prescribed medication globally since their discovery in the
1950s, the search for structurally related biologically active
compounds is of major relevance to the pharmaceutical
industry (Washton & Zweben, 2011). Previous work in our
group dealing with the construction of pyridodiazepinediones
(PZDs; Van den Bogaert et al., 2010) led unexpectedly to the
isolation of a tricyclic compound, which was later identified as
oxazolonaphthyridinone (ONO) 6 (Fig. 1). Commercially
available 2-hydroxynicotinic acid 1 was converted to dihalo-
nicotinic acid 3 via two sequential halogenation reactions (Van
den Bogaert et al., 2010; Gero et al., 1989; Hache´ et al., 2002),
after which a benzylamine substituent was introduced yielding
the aza-anthranilic acid derivative 4. Next, ester compound 5
was prepared from intermediate 4 and tert-butyl glycinate
using a standard coupling procedure. Finally, tert-butyl ester 5
was deprotected in situ and reacted with acetic anhydride in
the presence of potassium carbonate, yielding tricyclic
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Figure 1
Synthesis of the title compound 6 as unexpectedly formed during the
synthesis of pyridodiazepinediones.
compound 6. After exploration and optimization of the
revealed cascade reaction towards the closely related
oxazoloquinolinone scaffold (Vrijdag et al., 2013), we decided
to turn our attention to the remarkable tricyclic product 6
isolated during the initial investigation. The ONO structural
motif contained in compound 6 is brought into relation with
both antibacterial (Ratcliffe et al., 2015) and histamine 4
receptor antagonist (Ho et al., 2013) activities. Hence, new
synthetic routes towards ONOs are currently being developed
in our laboratory (Vrijdag et al., 2017). Here we present the
molecular and crystal structure of the title compound 6.
2. Structural commentary
Crystals of 6 belong to the orthorhombic space group Pna21
with one molecule in the asymmetric unit (Fig. 2). The
oxazolonaphthyridine ring is almost planar (r.m.s. deviation =
0.016 A˚) with the substituents C14 [0.082 (6) A˚], O15
[0.023 (4) A˚], Br16 [0.012 (1) A˚] and C17 [0.034 (5) A˚]
situated in the same plane (deviations from plane given in
parenthesis). The dihedral angle between the mean planes
through the oxazole and pyridine rings is 2.0 (2). The dihedral
angle between the oxazolonaphthyridine ring system and the
phenyl rings is 61.6 (2). Both H atoms of C17 are in close
contact with the neighboring atoms N8 and O15 (H17A  N8
= 2.36 A˚ and H17B  O15 = 2.36 A˚). No classical hydrogen
bonds are observed.
3. Supramolecular features
The crystal packing (Fig. 3) is characterized by – inter-
actions between the six-membered rings of the oxazolo-
naphthyridone ring systems, resulting in columns of stacked
molecules along the a axis [Fig. 4; Cg1  Cg1i = 3.494 (2) A˚
and Cg2  Cg2i = 3.906 (3) A˚; Cg1 and Cg2 are the centroids
of the rings C7/N8/C9–C12 and C4/C5/N6/C7/C12/C13,
respectively; symmetry code: (i) x + 12, y + 32, z]. Molecules in
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Figure 2
View of the asymmetric unit of the title compound 6, showing the atom-
labelling scheme. Displacement ellipsoids are drawn at the 50%
probability level. H atoms are shown as small circles of arbitrary radii.
Figure 3
View of the crystal packing for the title compound 6, showing C—H  
interactions (red dotted lines) between the C18–C23 phenyl rings.
Table 1
Hydrogen-bond geometry (A˚, ).
Cg3 is the centroid of the C18–C23 ring.
D—H  A D—H H  A D  A D—H  A
C21—H21  Cg3i 0.95 2.82 3.604 (6) 141
C11—H11  Cg3ii 0.95 3.31 4.239 (6) 167
Symmetry codes: (i) x  12;yþ 52; z; (ii) xþ 12;yþ 32; z.
neighboring columns show further C—H   interactions
between the C18–C23 phenyl rings (Fig. 3, Table 1). The
closest contact of Br16 in the packing is with atom O15ii
[2.874 (4) A˚; symmetry code: (ii) x + 12, y  12, z  12].
4. Database survey
A search of the Cambridge Structural Database (CSD,
Version 5.38, last update February 2017; Groom et al., 2016)
for a [1,3]oxazolo[4,5-c]-1,8-naphthyridin-4(5H)-one ring
skeleton gave no hits. The closest ring skeleton is found in
2,5-dimethyl[1,3]oxazolo[4,5-c]quinolin-4(5H)-one (refcode
HOJTUW; Latypov et al., 2008), which contains a quinolinone
ring system instead of a naphthyridinone ring system. The
oxazoloquinoline ring is almost planar (r.m.s. deviation =
0.015 A˚) with a dihedral angle between the oxazole and
phenyl rings of 1.90 (13).
5. Synthesis and crystallization
Synthesis of 5-bromo-2-hydroxynicotinic acid (2), 5-bromo-2-
chloronicotinic acid (3), and 2-(benzylamino)-5-bromo-
nicotinic acid (4):
Substituted nicotinic acids 2–4 were synthesized following
the protocols of Van den Bogaert et al. (2010). Analytical data
matches literature data.
Synthesis of tert-butyl N-{[2-(benzylamino)-5-bromo-
pyridin-3-yl]carbonyl}glycinate (5):
2-(Benzylamino)-5-bromonicotinic acid 4 (50 mg,
0.16 mmol) was dissolved in dimethylformamide under an Ar
atmosphere, and di-isopropylethylamine (27 ml, 0.16 mmol)
and benzotriazolyl tetramethyluronium fluoroborate (TBTU,
57 mg, 0.18 mmol) were subsequently added to the mixture.
The reaction was stirred at room temperature for 15 m, and
t-butyl glycinate (24 ml, 0.18 mmol) was added. The reaction
was continued at room temperature for 18 h, after which the
mixture was concentrated under reduced pressure. The
residue was purified using silica gel chromatography (heptane/
ethyl acetate, 8:2 v/v) to yield compound 5 (64 mg, yield 95%).
IR (Perkin–Elmer 1720 FTIR, KBr, cm1):  = 1705 (s, CO
ester), 1648 (s, CO amide). 1H NMR [Bruker 400 Avance,
400 MHz, CDCl3,  (ppm), J (Hz)]: 8.42 (t, 1H, J = 5, CH), 8.21
(d, 1H, J = 2, CH), 7.76 (d, 1H, J = 2, CH), 7.34–7.22 (m, 5H,
CH), 6.84 (t, 1H, J = 5, CH), 4.65 (d, 2H, J = 6, CH2), 4.02 (d,
2H, J = 5, CH2), 1.49 (s, 9H, CH3).
13C NMR [Bruker 400
Avance, 101 MHz, CDCl3,  (ppm)]: 169.4, 167.1, 156.3, 152.6,




A mixture of tert-butyl N-{[2-(benzylamino)-5-bromo-
pyridin-3-yl]carbonyl}glycinate 5 (50 mg, 0.12 mmol) and di-
chloromethane (2.25 mL) was cooled to 273 K, after which
trifluoroacetic acid (0.75 mL) was added. The reaction was
continued at room temperature for 16 h, concentrated under
reduced pressure, and dried under high vacuum. The obtained
crude acid was combined with K2CO3 (38 mg, 0.28 mmol) and
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Figure 4
Part of the crystal packing of the title compound 6, showing –







Crystal system, space group Orthorhombic, Pna21
Temperature (K) 200
a, b, c (A˚) 6.7150 (13), 13.504 (3), 16.757 (3)
V (A˚3) 1519.5 (5)
Z 4
Radiation type Mo K
 (mm1) 2.72
Crystal size (mm) 0.3  0.3  0.2
Data collection
Diffractometer Enraf–Nonius CAD-4
Absorption correction  scan (North et al., 1968)
Tmin, Tmax 0.522, 0.578
No. of measured, independent and






R[F 2 > 2(F 2)], wR(F 2), S 0.027, 0.069, 1.16
No. of reflections 1429
No. of parameters 209
No. of restraints 1





Absolute structure No quotients, so Flack parameter
determined by classical intensity
fit
Absolute structure parameter 0.000 (12)
Computer programs: CAD-4 EXPRESS (Enraf–Nonius, 1989),DREAR (Blessing, 1987),
SHELXS (Sheldrick, 2008), SHELXL2014/7 (Sheldrick, 2015) and OLEX2 (Dolomanov
et al., 2009).
acetic anhydride (0.5 mL) under an Ar atmosphere and the
mixture was stirred at room temperature for 30 m. Subse-
quently the reaction was heated to reflux for 24 h, after which
the mixture was concentrated under reduced pressure. The
residue was purified using silica gel chromatography (di-
chloromethane/methanol, 99:1 v/v) to yield the title compound
(12 mg, yield 27%). Light-brown prismatic crystals were
grown by diffusion of pentane in a chloroform solution of the
title compound.
IR (Perkin–Elmer 1720 FTIR, NaCl, cm1):  = 1683 (s, CO
amide). 1H NMR [Bruker 400 Avance, 400 MHz, CDCl3, 
(ppm), J (Hz)]: 8.65 (d, 1H, J = 2, CH), 8.27 (d, 1H, J = 2, CH),
7.48 (dd, 2H, J = 7, 1, CH), 7.26–7.21 (m, 3H, CH), 5.80 (s, 2H,
CH2), 2.71 (s, 3H, CH3).
13C NMR [Bruker 400 Avance,
101 MHz, CDCl3,  (ppm)]: 164.6, 157.3, 150.2, 149.9, 146.6,
137.5, 131.5, 131.0, 128.9, 128.4, 127.5, 113.9, 108.5, 44.8, 14.5.
6. Refinement
Crystal data, data collection and structure refinement details
are summarized in Table 2. All H atoms were placed in
calculated positions with C—H = 0.95 A˚ for aromatic, C—H =
0.98 A˚ for CH3 or C—H = 0.99 A˚ for CH2 H atoms, and
included in the refinement in a riding model with Uiso(H) = 1.2
or 1.5Ueq(C).
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Computing details 
Data collection: CAD-4 EXPRESS (Enraf–Nonius, 1989); cell refinement: CAD-4 EXPRESS (Enraf–Nonius, 1989); data 
reduction: DREAR (Blessing, 1987); program(s) used to solve structure: SHELXS (Sheldrick, 2008); program(s) used to 
refine structure: SHELXL2014/7 (Sheldrick, 2015); molecular graphics: OLEX2 (Dolomanov et al., 2009); software used 






a = 6.7150 (13) Å
b = 13.504 (3) Å
c = 16.757 (3) Å
V = 1519.5 (5) Å3
Z = 4
F(000) = 744
Dx = 1.618 Mg m−3
Mo Kα radiation, λ = 0.71073 Å
Cell parameters from 25 reflections
θ = 1.9–25.3°
µ = 2.72 mm−1
T = 200 K
Prism, light brown




Radiation source: fine-focus sealed tube
Graphite monochromator
ω/2θ scans
Absorption correction: ψ scan 
(North et al., 1968)
Tmin = 0.522, Tmax = 0.578
1429 measured reflections
1429 independent reflections
1279 reflections with I > 2σ(I)
Rint = 0.049















Primary atom site location: structure-invariant 
direct methods
Hydrogen site location: inferred from 
neighbouring sites
H-atom parameters constrained
w = 1/[σ2(Fo2) + (0.0221P)2 + 0.5935P] 
where P = (Fo2 + 2Fc2)/3
(Δ/σ)max < 0.001
Δρmax = 0.34 e Å−3
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Δρmin = −0.27 e Å−3 Absolute structure: No quotients, so Flack 
parameter determined by classical intensity fit
Absolute structure parameter: 0.000 (12)
Special details 
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance 
matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; 
correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate 
(isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) 
x y z Uiso*/Ueq
O1 0.1853 (5) 0.6350 (2) 1.0622 (2) 0.0353 (7)
C2 0.1680 (7) 0.6538 (4) 1.1434 (3) 0.0408 (11)
N3 0.1585 (6) 0.7463 (3) 1.1614 (2) 0.0430 (10)
C4 0.1733 (6) 0.7940 (4) 1.0879 (3) 0.0344 (10)
C5 0.1745 (8) 0.8991 (4) 1.0713 (3) 0.0347 (11)
N6 0.1944 (5) 0.9220 (3) 0.9912 (2) 0.0311 (8)
C7 0.2122 (7) 0.8525 (3) 0.9299 (3) 0.0261 (10)
N8 0.2338 (5) 0.8876 (3) 0.8560 (3) 0.0324 (8)
C9 0.2503 (6) 0.8216 (4) 0.7968 (3) 0.0352 (10)
H9 0.2659 0.8454 0.7438 0.042*
C10 0.2456 (6) 0.7205 (3) 0.8090 (3) 0.0327 (10)
C11 0.2253 (6) 0.6834 (3) 0.8840 (3) 0.0299 (9)
H11 0.2232 0.6140 0.8929 0.036*
C12 0.2078 (6) 0.7493 (3) 0.9470 (2) 0.0269 (9)
C13 0.1890 (6) 0.7265 (3) 1.0287 (3) 0.0299 (9)
C14 0.1651 (9) 0.5668 (5) 1.1959 (4) 0.0590 (16)
H14A 0.1328 0.5876 1.2504 0.089*
H14B 0.2962 0.5350 1.1953 0.089*
H14C 0.0643 0.5199 1.1770 0.089*
O15 0.1582 (6) 0.9635 (3) 1.1226 (2) 0.0501 (9)
Br16 0.26869 (6) 0.63431 (3) 0.72061 (4) 0.04509 (16)
C17 0.2032 (7) 1.0293 (3) 0.9709 (3) 0.0359 (10)
H17A 0.2912 1.0383 0.9241 0.043*
H17B 0.2634 1.0656 1.0163 0.043*
C18 0.0019 (6) 1.0740 (3) 0.9526 (3) 0.0360 (10)
C19 −0.1165 (8) 1.1102 (4) 1.0132 (4) 0.0456 (13)
H19 −0.0752 1.1033 1.0671 0.055*
C20 −0.2946 (10) 1.1562 (5) 0.9957 (5) 0.0567 (18)
H20 −0.3748 1.1810 1.0379 0.068*
C21 −0.3576 (8) 1.1669 (4) 0.9187 (4) 0.0534 (15)
H21 −0.4804 1.1990 0.9075 0.064*
C22 −0.2419 (8) 1.1307 (4) 0.8573 (4) 0.0514 (16)
H22 −0.2840 1.1380 0.8035 0.062*
C23 −0.0632 (8) 1.0834 (4) 0.8746 (3) 0.0476 (13)
H23 0.0152 1.0572 0.8324 0.057*
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Atomic displacement parameters (Å2) 
U11 U22 U33 U12 U13 U23
O1 0.0308 (15) 0.0340 (17) 0.0412 (18) 0.0005 (12) −0.0015 (14) 0.0023 (14)
C2 0.029 (2) 0.053 (3) 0.040 (3) 0.003 (2) −0.001 (2) 0.006 (2)
N3 0.031 (2) 0.060 (3) 0.037 (2) 0.0057 (18) −0.0035 (18) −0.001 (2)
C4 0.022 (2) 0.043 (3) 0.038 (3) 0.006 (2) −0.0047 (19) −0.008 (2)
C5 0.028 (3) 0.039 (3) 0.037 (3) 0.001 (2) −0.008 (2) −0.012 (2)
N6 0.0261 (17) 0.0250 (18) 0.042 (2) −0.0009 (15) 0.0004 (16) −0.0089 (16)
C7 0.018 (2) 0.028 (2) 0.033 (2) −0.0013 (18) 0.0012 (19) −0.0084 (19)
N8 0.0262 (17) 0.030 (2) 0.041 (2) 0.0006 (14) 0.0026 (16) −0.0028 (17)
C9 0.028 (2) 0.042 (3) 0.035 (2) 0.0009 (19) 0.0039 (19) −0.006 (2)
C10 0.022 (2) 0.034 (2) 0.042 (2) −0.0003 (17) 0.0011 (18) −0.0154 (19)
C11 0.022 (2) 0.027 (2) 0.041 (2) 0.0004 (18) −0.0027 (18) −0.0099 (19)
C12 0.0164 (19) 0.027 (2) 0.037 (2) −0.0007 (15) −0.0006 (17) −0.0069 (18)
C13 0.0204 (19) 0.027 (2) 0.043 (3) 0.0006 (16) −0.0016 (18) −0.0008 (18)
C14 0.053 (3) 0.072 (4) 0.053 (3) 0.006 (3) −0.003 (2) 0.022 (3)
O15 0.057 (2) 0.049 (2) 0.044 (2) 0.0047 (18) −0.0070 (18) −0.0256 (17)
Br16 0.0427 (2) 0.0502 (3) 0.0424 (2) −0.0015 (2) 0.0038 (4) −0.0214 (3)
C17 0.036 (2) 0.023 (2) 0.049 (3) −0.0021 (17) 0.002 (2) −0.011 (2)
C18 0.035 (2) 0.020 (2) 0.052 (3) −0.0044 (17) 0.002 (2) −0.002 (2)
C19 0.045 (3) 0.038 (3) 0.054 (3) 0.007 (2) 0.011 (3) 0.002 (2)
C20 0.049 (4) 0.043 (3) 0.078 (5) 0.013 (3) 0.014 (4) 0.008 (3)
C21 0.037 (3) 0.032 (3) 0.092 (5) 0.001 (2) −0.009 (3) 0.007 (3)
C22 0.056 (4) 0.040 (3) 0.058 (4) −0.010 (3) −0.011 (3) 0.006 (2)
C23 0.053 (3) 0.033 (3) 0.056 (3) −0.003 (2) 0.003 (3) −0.003 (2)
Geometric parameters (Å, º) 
O1—C2 1.389 (6) C11—C12 1.386 (6)
O1—C13 1.358 (5) C12—C13 1.408 (6)
C2—N3 1.287 (6) C14—H14A 0.9800
C2—C14 1.467 (7) C14—H14B 0.9800
N3—C4 1.393 (6) C14—H14C 0.9800
C4—C5 1.446 (7) C17—H17A 0.9900
C4—C13 1.352 (6) C17—H17B 0.9900
C5—N6 1.384 (7) C17—C18 1.512 (6)
C5—O15 1.229 (6) C18—C19 1.379 (7)
N6—C7 1.396 (6) C18—C23 1.383 (7)
N6—C17 1.489 (6) C19—H19 0.9500
C7—N8 1.335 (7) C19—C20 1.380 (9)
C7—C12 1.423 (6) C20—H20 0.9500
N8—C9 1.338 (6) C20—C21 1.365 (10)
C9—H9 0.9500 C21—H21 0.9500
C9—C10 1.381 (7) C21—C22 1.379 (9)
C10—C11 1.359 (7) C22—H22 0.9500
C10—Br16 1.890 (4) C22—C23 1.390 (7)
C11—H11 0.9500 C23—H23 0.9500
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C13—O1—C2 103.9 (4) C4—C13—C12 125.0 (4)
O1—C2—C14 116.2 (4) C2—C14—H14A 109.5
N3—C2—O1 114.3 (4) C2—C14—H14B 109.5
N3—C2—C14 129.5 (5) C2—C14—H14C 109.5
C2—N3—C4 103.8 (4) H14A—C14—H14B 109.5
N3—C4—C5 128.6 (4) H14A—C14—H14C 109.5
C13—C4—N3 110.1 (4) H14B—C14—H14C 109.5
C13—C4—C5 121.3 (4) N6—C17—H17A 108.9
N6—C5—C4 114.0 (4) N6—C17—H17B 108.9
O15—C5—C4 124.1 (5) N6—C17—C18 113.6 (3)
O15—C5—N6 121.9 (5) H17A—C17—H17B 107.7
C5—N6—C7 124.8 (4) C18—C17—H17A 108.9
C5—N6—C17 116.3 (4) C18—C17—H17B 108.9
C7—N6—C17 118.9 (4) C19—C18—C17 120.4 (5)
N6—C7—C12 120.6 (4) C19—C18—C23 118.8 (5)
N8—C7—N6 116.9 (4) C23—C18—C17 120.8 (5)
N8—C7—C12 122.5 (4) C18—C19—H19 119.9
C7—N8—C9 117.4 (4) C18—C19—C20 120.2 (6)
N8—C9—H9 118.4 C20—C19—H19 119.9
N8—C9—C10 123.1 (5) C19—C20—H20 119.4
C10—C9—H9 118.4 C21—C20—C19 121.1 (6)
C9—C10—Br16 119.4 (4) C21—C20—H20 119.4
C11—C10—C9 120.3 (4) C20—C21—H21 120.2
C11—C10—Br16 120.4 (3) C20—C21—C22 119.5 (6)
C10—C11—H11 120.8 C22—C21—H21 120.2
C10—C11—C12 118.5 (4) C21—C22—H22 120.2
C12—C11—H11 120.8 C21—C22—C23 119.5 (6)
C11—C12—C7 118.2 (4) C23—C22—H22 120.2
C11—C12—C13 127.5 (4) C18—C23—C22 120.8 (6)
C13—C12—C7 114.3 (4) C18—C23—H23 119.6
O1—C13—C12 127.1 (4) C22—C23—H23 119.6
C4—C13—O1 107.9 (4)
O1—C2—N3—C4 −0.9 (6) N8—C9—C10—C11 −0.6 (7)
C2—O1—C13—C4 −0.3 (4) N8—C9—C10—Br16 179.6 (3)
C2—O1—C13—C12 179.0 (4) C9—C10—C11—C12 0.6 (6)
C2—N3—C4—C5 −179.0 (5) C10—C11—C12—C7 −0.1 (6)
C2—N3—C4—C13 0.7 (5) C10—C11—C12—C13 −178.8 (4)
N3—C4—C5—N6 179.1 (4) C11—C12—C13—O1 0.4 (7)
N3—C4—C5—O15 −1.4 (8) C11—C12—C13—C4 179.7 (4)
N3—C4—C13—O1 −0.2 (5) C12—C7—N8—C9 0.5 (6)
N3—C4—C13—C12 −179.6 (4) C13—O1—C2—N3 0.8 (5)
C4—C5—N6—C7 0.0 (7) C13—O1—C2—C14 −178.6 (4)
C4—C5—N6—C17 −178.1 (4) C13—C4—C5—N6 −0.5 (6)
C5—C4—C13—O1 179.5 (4) C13—C4—C5—O15 179.0 (5)
C5—C4—C13—C12 0.1 (7) C14—C2—N3—C4 178.4 (5)
C5—N6—C7—N8 −178.8 (4) O15—C5—N6—C7 −179.5 (5)
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C5—N6—C7—C12 0.9 (7) O15—C5—N6—C17 2.4 (7)
C5—N6—C17—C18 −91.6 (5) Br16—C10—C11—C12 −179.7 (3)
N6—C7—N8—C9 −179.8 (4) C17—N6—C7—N8 −0.8 (6)
N6—C7—C12—C11 179.8 (4) C17—N6—C7—C12 179.0 (4)
N6—C7—C12—C13 −1.3 (6) C17—C18—C19—C20 176.1 (5)
N6—C17—C18—C19 86.4 (5) C17—C18—C23—C22 −175.5 (4)
N6—C17—C18—C23 −96.4 (5) C18—C19—C20—C21 0.1 (9)
C7—N6—C17—C18 90.2 (5) C19—C18—C23—C22 1.7 (7)
C7—N8—C9—C10 0.1 (6) C19—C20—C21—C22 0.3 (10)
C7—C12—C13—O1 −178.4 (4) C20—C21—C22—C23 0.4 (8)
C7—C12—C13—C4 0.9 (6) C21—C22—C23—C18 −1.4 (8)
N8—C7—C12—C11 −0.5 (6) C23—C18—C19—C20 −1.1 (7)
N8—C7—C12—C13 178.5 (4)
Hydrogen-bond geometry (Å, º) 
Cg3 is the centroid of the C18–C23 ring.
D—H···A D—H H···A D···A D—H···A
C21—H21···Cg3i 0.95 2.82 3.604 (6) 141
C11—H11···Cg3ii 0.95 3.31 4.239 (6) 167
Symmetry codes: (i) x−1/2, −y+5/2, z; (ii) x+1/2, −y+3/2, z.
